EP0603270A1 - Wettable silicone hydrogel compositions and methods for making them - Google Patents

Wettable silicone hydrogel compositions and methods for making them

Info

Publication number
EP0603270A1
EP0603270A1 EP92919325A EP92919325A EP0603270A1 EP 0603270 A1 EP0603270 A1 EP 0603270A1 EP 92919325 A EP92919325 A EP 92919325A EP 92919325 A EP92919325 A EP 92919325A EP 0603270 A1 EP0603270 A1 EP 0603270A1
Authority
EP
European Patent Office
Prior art keywords
silicone
containing monomer
carbon atoms
group
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP92919325A
Other languages
German (de)
French (fr)
Inventor
Yu-Chin Lai
Gary D. Friends
Paul L. Valint, Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bausch and Lomb Inc
Original Assignee
Bausch and Lomb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch and Lomb Inc filed Critical Bausch and Lomb Inc
Publication of EP0603270A1 publication Critical patent/EP0603270A1/en
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041Lenses
    • G02B1/043Contact lenses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F299/00Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers
    • C08F299/02Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates
    • C08F299/08Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers from unsaturated polycondensates from polysiloxanes

Definitions

  • the present invention relates to improved polymeric silicone-containing hydrogel compositions useful for the production of biomedical devices, especially contact lenses.
  • Hydrogels have been a desirable material for the preparation of biomedical devices, and have been known since at least ichterle, et al U.S. Patent No. 3,220,960 which disclosed hydrogels comprising a hydrated polymer of a hydroxyalkyl acrylate or methacrylate crosslinked with a corresponding diester (poly 2-hydroxyethyl methacrylate, known as HEMA) .
  • HEMA poly 2-hydroxyethyl methacrylate
  • a hydrogel is a hydrated crosslinked polymeric system that contains water in an equilibrium state.
  • the physical properties of hydrogels can vary widely and are mostly determined by their water content. Since hydrogels exhibit excellent biocompatibility, there has been extensive interest in the use of hydrogels for biomedical devices, especially contact lenses. In the field of contact lenses, various factors combine to yield a material that has appropriate characteristics. Oxygen permeability, wettability, material strength and stability are but a few of the factors which must be carefully balanced to achieve a useable end-result contact lens. Since the cornea receives its oxygen supply exclusively from contact with the atmosphere, good oxygen permeability is a critical characteristic for any contact lens material.
  • High water-containing hydrogels have at times exhibited undesirable mechanical properties. For example, such hydrogels are not easily formed into hydrolytically stable lenses. Further such materials have at times exhibited tearing or other breakage as a result of poor tensile strength. What was needed was a highly oxygen permeable material that was durable and highly wettable. Wettability is important in that if the lens is not sufficiently wettable, it does not remain lubricated and therefore cannot be worn comfortably on the eye. The optimal contact lens would have not only excellent oxygen permeability, but also excellent tear fluid wettability.
  • Silicone-containing materials were tried as viable contact lens materials and displayed very good oxygen permeability and durability. However, most silicone- containing materials are largely hydrophobic and therefore not sufficiently wettable. Further, it is believed that such hydrophobicity causes enhanced deposit problems, which may result in discomfort when wearing contact lenses made from these silicone- containing polymers.
  • an optimal hydrogel material for biomedical devices such as contact lenses, would have ideal rigidity, high oxygen permeability and a high degree of wettability.
  • the surface wettability of hydrogels such as silicone-containing hydrogels, and more specifically urethane prepolymeric hydrogels and ethylenically terminated polysiloxane hydrogels, can be significantly enhanced by the addition of at least one ethylenically unsaturated dibasic acid or corresponding anhydride monomer in the monomer mix. It is believed that these hydrophilic dibasic acid monomers react with the predominantly hydrophobic silicone-containing monomers and prepolymers to produce highly wettable hydrogels.
  • a method for making a wettable silicone-containing hydrogel composition comprising the steps of a) combining an ethylenically unsaturated dibasic acid or acid anhydride and at least one silicone- containing prepolymer into a monomer mix and b) curing the monomer mix resulting from step a) to form a silicone-containing hydrogel composition.
  • the present invention relates to improved wettability of hydrogels, especially silicone-containing hydrogels with ideal rigidity suitable for biomedical applications such as contact lenses.
  • silicone-containing hydrogels of the present invention display improved wettability as a result of the presence of an ethylenically unsaturated dibasic acid or corresponding acid anhydride in the monomer mix with the silicone-containing monomer or prepolymer.
  • Silicone hydrogels i.e., hydrogels containing silicone
  • silicone-containing monomer or the hydrophilic monomer may function as a crosslinking agent (a crosslinker being defined as a monomer having multiple polymerizable fuctionalities) or a separate crosslinker may be employed.
  • any known silicone-containing monomer may be used in the process of this invention to form the silicone hydrogels of this invention, as will be apparent to one skilled in the art.
  • the monomers added to the monomeric mixture may be monomers or prepolymers.
  • a "prepolymer” is a reaction intermediate polymer of medium molecular weight having polymerizable groups.
  • silicon-containing monomers and “hydrophilic monomers” include prepolymers. Examples of such monomers may be found in United States Patent NOS. 4,136,250; 4,153,641; 4,740,533; 5,034,461; and 5,070,215.
  • Additional crosslinking agents which may be incorporated into the silicone-containing hydrogel of the present invention include polyvinyl, typically di- or tri-vinyl monomers, most commonly the di- or tri( eth)acrylates of dihydric ethylene glycol, triethylene glycol, butylene glycol, hexane-l,6-diol, thio-diethylene glycol-diacrylate and methacrylate; neopentyl glycol diacrylate; trimethylolpropane triacrylate and the like; N,N'-dihydroxyethylene- bisacrylamide and -bismethacrylamides; also diallyl compounds like diallyl phthalate and triallyl cyanurate; divinylbenzene; ethylene glycol divinyl ether; and the (meth)acrylate esters of polyols such as triethanolamine, glycerol, pentanerythritol, butylene glycol, mannitol, and sorbitol.
  • illustrations include N,N-methylene-bis-(meth)acrylamide, sulfonated divinylbenzene, and divinylsulfone.
  • reaction products of hydroxyalkyl (meth)acrylates with unsaturated isocyanates for example the reaction product of 2-hydroxyethyl methacrylate with 2- i ⁇ ocyanatoethyl methacrylate (IEM) as disclosed in U.S. Patent No. 4,954,587.
  • crosslinking agents are polyether- bisurethane-dimethacrylates as described in U.S. Patent No. 4,192,827, and those crosslinkers obtained by reaction of polyethylene glycol, polypropylene glycol and polytetramethylene glycol with 2-isocyanatoethyl methacrylate (IEM) or m-isopropenyl- , ⁇ -dimethylbenzyl isocyanates (m-TMI) , and polysiloxane-bisurethane- dimethacrylates as described in U.S. Patent Nos. 4,486,577 and 4,605,712.
  • IEM 2-isocyanatoethyl methacrylate
  • m-TMI m-isopropenyl- , ⁇ -dimethylbenzyl isocyanates
  • polysiloxane-bisurethane- dimethacrylates as described in U.S. Patent Nos. 4,486,577 and 4,605,712.
  • Still other known crosslinking agents are the reaction products of polyvinyl alcohol, ethoxylated polyvinyl alcohol or of polyvinyl alcohol- co-ethylene with 0.1 to 10 mol % vinyl isocyanates like IEM or m-TMI.
  • One preferred class of suitable silicone-containing monomers contemplated by the present invention are bulky polysiloxanylalkyl (meth)acrylic monomers represented by the formula (I) :
  • X is 0 or NR; each R is independently hydrogen or methyl; and each R is independently a lower alkyl or phenyl group; and f is 1 or 3 to 10.
  • Such bulky monomers include methacryloxypropyl tris(trimethylsiloxy)silane, pentamethyldisiloxanylmethylmethacrylate, tris(trimethylsiloxy)methacryloxy propylsilane, phenyltetramethyldisiloxanylethyl acetate, and methyldi(trimethylsiloxy)methacryloxymethyl silane.
  • a further preferred class of silicone-containing monomers is a poly(organosiloxane) prepolymer represented by the formula (II) :
  • A is an activated unsaturated group, such as an ester or amide of an acrylic or a methacrylic acid; each R 3 -R 6 is independently selected from the group consisting of a monovalent hydrocarbon radical or a halogen substituted monovalent hydrocarbon radical having 1 to 18 carbon atoms which may have ether linkages between carbon atoms;
  • R 7 is a divalent hydrocarbon radical having from 1 to 22 carbon atoms; and n is 0 or an integer greater than or equal to 1.
  • a further preferred class of silicone-containing monomers are the monomers having the following schematic representations:
  • D denotes an alkyl diradical, an alkyl cycloalkyl diradical, a cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 6 to 30 carbon atoms;
  • G denotes an alkyl diradical, a cycloalkyl diradical, an alkyl cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 1 to 40 carbon atoms and which may contain ether, thio or amine linkages in the main chain;
  • * denotes a urethane or ureido linkage; a is at least 1;
  • A" denotes a divalent polymeric radical of formula (V):
  • R s and R s independently denote an alkyl or fluoro-substituted alkyl group having 1 to 10 carbon atoms which may contain ether linkages between carbon atoms; m is at least 1; and p provides a moiety weight of 400 to 10,000;
  • E and E' independently denote a polymerizable unsaturated organic radical represented by formula (VI) :
  • R 13 -CH C-(CH 2 ) w -(X)x-(2) z -(Ar) y -R 14 - wherein: R 14 denotes a divalent alkylene radical having 1 to 10 carbon atoms;
  • R 12 denotes H or CH 3 ;
  • Y is -0-, -S- or -NH- and R 15 is a alkyl radical having 1 to 12 carbon atoms;
  • X is -CO- or -0C0-
  • Z is -O- or -NH-
  • Ar denotes an aromatic radical having 6 to 30 carbon atoms; w is 0 to 6; x is 0 or 1; y is 0 or 1; and z is 0 or 1.
  • a preferred urethane monomer is represented by formula (VII) : u
  • H 2 C C H H H H 1 ( I I COOCH 2 CH 2 OCN-R 16 -NCOCH 2 CH 2 OCH 2 CH 2 OCN-R 16 -NCO
  • R 16 is a diradical of a diisocyanate after removal of the isocyanate group, and is most preferably the diradical of isophorone diisocyanate, and m, p and a are the same as previously defined.
  • the sum of m and a is 3 or 4, and more preferably, a is 1 and m is 3 or 4.
  • p is at least 30.
  • hydrogel contact lenses should have oxygen permeabilities with DK values greater than 20 x lO ""11 cm 3 x cm/sec x cm 2 x mmHg (or DK units) and preferably greater than 60 DK. They should have a Young's modulus of elasticity in the range of 5 to 400 g/mm 2 , preferably greater than 20g/mm 2 as measured by ASTM test method D1938. Their water content should be between 10% to 80 %, and preferably between 20 to 60%.
  • the contact angle which is a measurement of the wettability of the lens, should be less than 80 degrees and should preferably be less than 40 degrees.
  • the present invention further provides articles of manufacture which can be used for biomedical devices, such as, surgical devices, heart valves, vessel substitutes, intrauterine devices, membranes and other films, diaphragms, catheters, mouth guards, denture liners, intraocular devices, and especially contact lenses.
  • biomedical devices such as, surgical devices, heart valves, vessel substitutes, intrauterine devices, membranes and other films, diaphragms, catheters, mouth guards, denture liners, intraocular devices, and especially contact lenses.
  • shaped articles for use in biomedical applications or “biomedical devices” mean the materials disclosed herein have physicochemical properties rendering them suitable for prolonged contact with living tissue, blood and the mucous membranes.
  • (meth)acrylaye includes both methyl acrylate and methyl methacrylate
  • N-alkyl (meth)acrylamide includes both N-alkyl acrylamide and N-alkyl methacrylamide
  • dibasic acid is understood by those skilled in the field to describe compounds which contain groups, each of which supplies an hydrogen atom.
  • the resulting polymeric film may have undesirable optical characteristics such as cloudiness, etc.
  • dibasic acids only half the weight percent of the amount of monobasic acid need be used to obtain a comparable effect on the polymeric mixture.
  • the preferred range of dibasic acid concentration is about from 0.5 weight percent of the polymeric hydrogel mix to about 10 weight percent, and more preferably from about 2 weight percent to about 5 weight percent.
  • the resulting hydrogels of the present invention show great promise as a superior material for various biomedical devices such as surgical implants, blood vessels, artificial ureters, artificial breast tissue and membranes intended to come into contact with body fluid outside of the body, e.g., membranes for kidney dialysis and heart/lung machines and the like. It is known that blood, for example, is readily and rapidly damaged when it comes into contact with artificial surfaces. The design of a synthetic surface which is antithrombogenic and nonhemolytic to blood is necessary for prostheses and devices used with blood.
  • silicone-containing monomers contemplated by the present invention are urethane-containing prepolymers, and ethylenically terminated polysiloxane containing monomers, such as, most preferably , ⁇ bis(methacryloxybutyl)polysiloxane (M 2 D 2 s) .
  • the ethylenically unsaturated dibasic carboxylic acid containing monomer, (or the corresponding anhydride-containing monomer) of the present invention is preferably itaconic acid, maleic acid or their anhydrides, and fumaric acid, and most preferably are itaconic and maleic acid and their anhydrides.
  • the monomer mixes employed in this invention can be readily cured to cast shapes by conventional methods such as UV polymerization, or thermal polymerization, or combinations thereof, as commonly used in polymerizing ethylenically unsaturated compounds.
  • Representative free radical thermal polymerization initiators are organic peroxides, such as acetal peroxide, lauroyl peroxide, decanoyl peroxide, stearoyl peroxide, benzoyl peroxide, tertiarybutyl peroxypivalate, peroxydicarbonate, and the like, employed in a concentration of about 0.01 to 1 percent by weight of the total monomer mixture.
  • Representative UV initiators are those known in the field such as, benzoin methyl ether, benzoin ethyl ether, Darocure 1173, 1164, 2273, / ⁇ -
  • Polymerization of the crosslinker of this invention with other comonomers is generally performed in the presence of a diluent.
  • the polymerization product will then be in the form of a gel. If the diluent is nonagueous, the diluent must be removed from the gel and replaced with water through the use of extraction and hydration protocols well known to those skilled in the art.
  • the copolymer of the present invention may also include other monomers as will be apparent to one skilled in the art.
  • the monomer mix may include additional hydrophilic monomers such as N-vinyl pyrrolidone and N,N-dimethylacrylamide, colorants, or UV-absorbing and toughening agents such as those known in the contact lens art.
  • the polymers of this invention can be formed into contact lenses by ⁇ pincasting processes (such as those disclosed in U.S. Pat. Nos. 3,408,429 and 3,496,254), cast molding processes (such as those disclosed in U.S.
  • Polymerization may be conducted either in a spinning mold, or a stationary mold corresponding to a desired contact lens shape.
  • the lens may be further subjected to mechanical finishing, as occasion demands.
  • Polymerization may also be conducted in an appropriate mold or vessel to form buttons, plates or rods, which may then be processed
  • the hydrogels of the present invention are oxygen transporting, hydrolytically stable, biologically inert, and transparent.
  • the monomers and prepolymers employed in accordance with this invention are readily polymerized to form three dimensional networks which permit the transport of oxygen and are optically clear, strong and hydrophilic.
  • the relative softness or hardness of the contact lenses fabricated from the resulting polymer of this invention can be varied by deceasing or increasing the molecular weight of the polysiloxane prepolymer end- capped with the activated unsaturated group or by varying the percent of the comonomer. Generally, as the ratio of polysiloxane units to end-cap units increases, the softness of the material increases.
  • the hydrophilic ethylenically unsaturated dibasic acid monomers of the present invention significantly reduce the contact angle of the surface - a clear indication to those skilled in the field that enhanced wetting has occurred.
  • the resulting dibasic acid- or anhydride-treated silicone- containing hydrogels were unexpectedly hydrolytically stable, within an acceptable range, while collecting only an acceptable level of deposits.
  • the resulting polymers and copolymers disclosed herein can be boiled and/or autoclaved in water without being damaged whereby sterilization may be achieved.
  • an article formed from the disclosed polymers and copolymers may be used, for example, in surgery where an article is needed which is compatible with living tissue or with the mucous membranes.
  • a formulation containing the following was prepared: urethane prepolymer derived from isophorone diisocyanate, diethylene glycol, polysiloxanediol of molecular weight 3000 and 2-hydroxyethyl methacrylate, 35 parts; 3-methacryloxypropyl tris(trimethylsiloxy)silane, (TRIS), 35 parts; N,N- di ethyl acrylamide, 30 parts; n-hexanol, 40 parts; benzoin methyl ether, 0.2 part.
  • the resulting clear mix was then UV cured into films or filtered through a 1.2 micron filter into a clean glass vial ready for lens casting.
  • Monomer mix was prepared as in Example 1 with the addition of 2 parts of maleic, itaconic or fumaric acid to the monomer mix.
  • Monomer mix was prepared as in Example 1 with the addition of 2 parts of itaconic anhydride to the monomer mix.
  • the resultant formulations from Examples 1 - 5 were placed between glass plates and cured under UV for 2 hours. After the films were released from the glass, they were extracetd with ethanol for 16 hours and then boiled in water for 4 hours and placed in buffered saline at pH 7.4. The hydrogel films were then characterized for mechanical properties, oxygen permeability, contact angle and others.
  • hydrolytic stability data of the control hydrogel film and those modified with two parts of dibasic acids are listed below.
  • hydrogel films comprising 2 parts of itaconic acid and maleic acid were considered stable.
  • hydrogel films derived from a formulation containing methacrylic acid were not as hydrolytically stable.
  • the tests were accomplished by agitating hydrogel films of known weight, (usually 30-40 mg) in a vial containing a standard buffered saline (5 grams) with 500 ppm of lysozyme for a 7 day period.
  • the amount of lysozyme remaining in the solution was determined by UV spectroscopy and the lysozyme uptake was reported as micrograms of lysozyme per milligram of hydrogel film, using poly(hydroxyethylmethacrylate) (HEMA) hydrogel films as references.
  • HEMA poly(hydroxyethylmethacrylate)
  • a high level of lysozome uptake is not desirable in contact lenses. Such uptake decreases visual acuity and can result in adverse eye physiological side effects. While it is desirable to add ionic monomers into the silicone-containing hydrogel to improve wettability, the lysozome uptake level should remain at a low level.
  • the contact angles of the surface of the films prepared from formulations in Examples 1 and 2 were measured by the captive bubble technique.
  • the films were submerged in buffered saline solution and a bubble of air was attached to the undersurface of the film.
  • the angle made by the intersection of the lens and bubble surfaces was measured using a goniometer.
  • a lower contact angle represents a greater degree of hydrophilicity, or film surface wettability.
  • the comparative contact angles of control hydrogel films and those modified with dibasic acids are listed below.
  • a polyurethane monomer mix of composition described in Examples 1 and 2 was filtered through a disposable filter of pore size 1.2 microns, into a clean vial. Through an applicator, under an inert nitrogen atmosphere, 60-9Oul of the mix was injected onto a clean plastic mold (for the anterior surface of a lens) and then covered with a second plastic mold (forming the posterior surface of the lens) . The molds are then compressed and cured for 90 minutes in the presence of ultraviolet light (4200 microwatts/cm 2 ) . The molds were opened mechanically and put in a beaker containing aqueous ethanol. The lenses were released from the mold within 10 to 50 minutes. The lenses were then extracted with ethanol for 48 hours, boiled in distilled water for 4 hours and inspected for cosmetic quality and dimension. Lenses passing inspection were thermally disinfected in phosphate-buffered saline prior to on-eye evaluation.
  • the cast molded lenses described in Example 11 were evaluated on six subjects. In each test, a poly(HEMA) control lens was worn on eye one and the test lens on the other eye. The lenses were analyzed after a minimum of one hour of wear, and optimally for 6 hours, for wettability and surface deposition.
  • the wettability rating scale was 0-4 with 0 representing 2/3 of the anterior surface unwetted by the tear film and 4 representing complete wetting.
  • the deposition scale was also 0-4 with 0 representing no surface deposit and 4 representing multiple deposits of 0.5mm diameter or larger.
  • the results for the lenses of the control formulation made according to Example 1, was 2.0 for wetting and 1.6 for deposit after 1 hour of wear.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Eyeglasses (AREA)
  • Materials For Medical Uses (AREA)

Abstract

L'invention concerne des hydrogels améliorés contenant de la silicone, présentant une aptitude au mouillage améliorée, comprenant un monomère contenant de la silicone, des monomères hydrophiles, ainsi que des monomères contenant de l'acide carboxylique dibasic à insaturation éthylénique ou de l'anhydride d'acide.Disclosed are improved silicone-containing hydrogels having improved wettability comprising a silicone-containing monomer, hydrophilic monomers, as well as monomers containing dibasic ethylenically unsaturated carboxylic acid or anhydride. of acid.

Description

WETTABLE SILICONE HYDROGEL COMPOSITIONS AND METHODS BACKGROUND OF THE INVENTION This is a continuation-in-part application of copending application, Ser. No. 07/758 , 047 filed September 12 , 1991.
Field of the Invention
The present invention relates to improved polymeric silicone-containing hydrogel compositions useful for the production of biomedical devices, especially contact lenses.
Background
Hydrogels have been a desirable material for the preparation of biomedical devices, and have been known since at least ichterle, et al U.S. Patent No. 3,220,960 which disclosed hydrogels comprising a hydrated polymer of a hydroxyalkyl acrylate or methacrylate crosslinked with a corresponding diester (poly 2-hydroxyethyl methacrylate, known as HEMA) .
A hydrogel is a hydrated crosslinked polymeric system that contains water in an equilibrium state. The physical properties of hydrogels can vary widely and are mostly determined by their water content. Since hydrogels exhibit excellent biocompatibility, there has been extensive interest in the use of hydrogels for biomedical devices, especially contact lenses. In the field of contact lenses, various factors combine to yield a material that has appropriate characteristics. Oxygen permeability, wettability, material strength and stability are but a few of the factors which must be carefully balanced to achieve a useable end-result contact lens. Since the cornea receives its oxygen supply exclusively from contact with the atmosphere, good oxygen permeability is a critical characteristic for any contact lens material.
It was discovered in the field that certain crosslinked polymeric materials could be hydrated and retain their water content. It was further found that the higher the water content within contact lenses made from these crosslinked hydrogel polymers, the greater was the oxygen permeability through the lens to the cornea.
High water-containing hydrogels have at times exhibited undesirable mechanical properties. For example, such hydrogels are not easily formed into hydrolytically stable lenses. Further such materials have at times exhibited tearing or other breakage as a result of poor tensile strength. What was needed was a highly oxygen permeable material that was durable and highly wettable. Wettability is important in that if the lens is not sufficiently wettable, it does not remain lubricated and therefore cannot be worn comfortably on the eye. The optimal contact lens would have not only excellent oxygen permeability, but also excellent tear fluid wettability.
Silicone-containing materials were tried as viable contact lens materials and displayed very good oxygen permeability and durability. However, most silicone- containing materials are largely hydrophobic and therefore not sufficiently wettable. Further, it is believed that such hydrophobicity causes enhanced deposit problems, which may result in discomfort when wearing contact lenses made from these silicone- containing polymers.
Therefore, an optimal hydrogel material for biomedical devices, such as contact lenses, would have ideal rigidity, high oxygen permeability and a high degree of wettability.
SUMMARY OF THE INVENTION In accordance with this invention, the surface wettability of hydrogels such as silicone-containing hydrogels, and more specifically urethane prepolymeric hydrogels and ethylenically terminated polysiloxane hydrogels, can be significantly enhanced by the addition of at least one ethylenically unsaturated dibasic acid or corresponding anhydride monomer in the monomer mix. It is believed that these hydrophilic dibasic acid monomers react with the predominantly hydrophobic silicone-containing monomers and prepolymers to produce highly wettable hydrogels.
Further, in accordance with the instant invention, a method for making a wettable silicone-containing hydrogel composition is disclosed comprising the steps of a) combining an ethylenically unsaturated dibasic acid or acid anhydride and at least one silicone- containing prepolymer into a monomer mix and b) curing the monomer mix resulting from step a) to form a silicone-containing hydrogel composition.
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to improved wettability of hydrogels, especially silicone-containing hydrogels with ideal rigidity suitable for biomedical applications such as contact lenses.
The silicone-containing hydrogels of the present invention display improved wettability as a result of the presence of an ethylenically unsaturated dibasic acid or corresponding acid anhydride in the monomer mix with the silicone-containing monomer or prepolymer. Silicone hydrogels (i.e., hydrogels containing silicone) are usually prepared by polymerizing a mixture containing at least one silicone-containing monomer and at least one hydrophilic monomer. Either the silicone- containing monomer or the hydrophilic monomer may function as a crosslinking agent (a crosslinker being defined as a monomer having multiple polymerizable fuctionalities) or a separate crosslinker may be employed.
Any known silicone-containing monomer may be used in the process of this invention to form the silicone hydrogels of this invention, as will be apparent to one skilled in the art. The monomers added to the monomeric mixture may be monomers or prepolymers. A "prepolymer" is a reaction intermediate polymer of medium molecular weight having polymerizable groups. Thus it is understood that the terms "silicone-containing monomers" and "hydrophilic monomers" include prepolymers. Examples of such monomers may be found in United States Patent NOS. 4,136,250; 4,153,641; 4,740,533; 5,034,461; and 5,070,215.
Additional crosslinking agents which may be incorporated into the silicone-containing hydrogel of the present invention include polyvinyl, typically di- or tri-vinyl monomers, most commonly the di- or tri( eth)acrylates of dihydric ethylene glycol, triethylene glycol, butylene glycol, hexane-l,6-diol, thio-diethylene glycol-diacrylate and methacrylate; neopentyl glycol diacrylate; trimethylolpropane triacrylate and the like; N,N'-dihydroxyethylene- bisacrylamide and -bismethacrylamides; also diallyl compounds like diallyl phthalate and triallyl cyanurate; divinylbenzene; ethylene glycol divinyl ether; and the (meth)acrylate esters of polyols such as triethanolamine, glycerol, pentanerythritol, butylene glycol, mannitol, and sorbitol. Further, illustrations include N,N-methylene-bis-(meth)acrylamide, sulfonated divinylbenzene, and divinylsulfone. Also useful are the reaction products of hydroxyalkyl (meth)acrylates with unsaturated isocyanates, for example the reaction product of 2-hydroxyethyl methacrylate with 2- iεocyanatoethyl methacrylate (IEM) as disclosed in U.S. Patent No. 4,954,587.
Other known crosslinking agents are polyether- bisurethane-dimethacrylates as described in U.S. Patent No. 4,192,827, and those crosslinkers obtained by reaction of polyethylene glycol, polypropylene glycol and polytetramethylene glycol with 2-isocyanatoethyl methacrylate (IEM) or m-isopropenyl- ,ω -dimethylbenzyl isocyanates (m-TMI) , and polysiloxane-bisurethane- dimethacrylates as described in U.S. Patent Nos. 4,486,577 and 4,605,712. Still other known crosslinking agents are the reaction products of polyvinyl alcohol, ethoxylated polyvinyl alcohol or of polyvinyl alcohol- co-ethylene with 0.1 to 10 mol % vinyl isocyanates like IEM or m-TMI.
One preferred class of suitable silicone-containing monomers contemplated by the present invention are bulky polysiloxanylalkyl (meth)acrylic monomers represented by the formula (I) :
wherein:
X is 0 or NR; each R is independently hydrogen or methyl; and each R is independently a lower alkyl or phenyl group; and f is 1 or 3 to 10. Such bulky monomers include methacryloxypropyl tris(trimethylsiloxy)silane, pentamethyldisiloxanylmethylmethacrylate, tris(trimethylsiloxy)methacryloxy propylsilane, phenyltetramethyldisiloxanylethyl acetate, and methyldi(trimethylsiloxy)methacryloxymethyl silane.
A further preferred class of silicone-containing monomers is a poly(organosiloxane) prepolymer represented by the formula (II) :
R3 R5 R3 (II) A-(R7)-Si-[0-Si]n-0-Si-(R7)-A
R4 R6 R4
wherein:
A is an activated unsaturated group, such as an ester or amide of an acrylic or a methacrylic acid; each R3-R6 is independently selected from the group consisting of a monovalent hydrocarbon radical or a halogen substituted monovalent hydrocarbon radical having 1 to 18 carbon atoms which may have ether linkages between carbon atoms;
R7 is a divalent hydrocarbon radical having from 1 to 22 carbon atoms; and n is 0 or an integer greater than or equal to 1. A further preferred class of silicone-containing monomers are the monomers having the following schematic representations:
(III) E(*D*A"*D*G)a*D*A"*D*E'; or
(IV) E(*D*G*D*A")a*D*G*D*E'; where
D denotes an alkyl diradical, an alkyl cycloalkyl diradical, a cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 6 to 30 carbon atoms;
G denotes an alkyl diradical, a cycloalkyl diradical, an alkyl cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 1 to 40 carbon atoms and which may contain ether, thio or amine linkages in the main chain;
* denotes a urethane or ureido linkage; a is at least 1;
A" denotes a divalent polymeric radical of formula (V):
Rs
(V) -(CH2 )n- -Si-o- -Si (CH2)m-
T-S'
P R5 wherein: Rs and Rs independently denote an alkyl or fluoro-substituted alkyl group having 1 to 10 carbon atoms which may contain ether linkages between carbon atoms; m is at least 1; and p provides a moiety weight of 400 to 10,000;
E and E' independently denote a polymerizable unsaturated organic radical represented by formula (VI) :
R12 I
(VI) R13-CH=C-(CH2)w-(X)x-(2)z-(Ar)y-R14- wherein: R14 denotes a divalent alkylene radical having 1 to 10 carbon atoms;
R12 denotes H or CH3;
,13 denotes H, a (C^-Cg) alkyl radical or a
-CO-Y-R15 group wherein Y is -0-, -S- or -NH- and R15 is a alkyl radical having 1 to 12 carbon atoms;
X is -CO- or -0C0-;
Z is -O- or -NH-;
Ar denotes an aromatic radical having 6 to 30 carbon atoms; w is 0 to 6; x is 0 or 1; y is 0 or 1; and z is 0 or 1. A preferred urethane monomer is represented by formula (VII) : u
CH3-Si-CH3 I (CH2)n
CH3 a
H2C=C H H H H 1 ( I I COOCH2CH2OCN-R16-NCOCH2CH2OCH2CH2OCN-R16-NCO
|! K li /I
0 0 o o
wherein:
R16 is a diradical of a diisocyanate after removal of the isocyanate group, and is most preferably the diradical of isophorone diisocyanate, and m, p and a are the same as previously defined. Preferably, the sum of m and a is 3 or 4, and more preferably, a is 1 and m is 3 or 4. Preferably, p is at least 30.
It is contemplated that the wettable silicone- containing hydrogels of the present invention, when used in contact lens applications, can produce a wide variety of types of hydrogel contact lenses. As is understood in the field, in general, hydrogel contact lenses should have oxygen permeabilities with DK values greater than 20 x lO""11 cm3 x cm/sec x cm2 x mmHg (or DK units) and preferably greater than 60 DK. They should have a Young's modulus of elasticity in the range of 5 to 400 g/mm2, preferably greater than 20g/mm2 as measured by ASTM test method D1938. Their water content should be between 10% to 80 %, and preferably between 20 to 60%. The contact angle, which is a measurement of the wettability of the lens, should be less than 80 degrees and should preferably be less than 40 degrees.
The present invention further provides articles of manufacture which can be used for biomedical devices, such as, surgical devices, heart valves, vessel substitutes, intrauterine devices, membranes and other films, diaphragms, catheters, mouth guards, denture liners, intraocular devices, and especially contact lenses.
The terms "shaped articles for use in biomedical applications" or "biomedical devices" mean the materials disclosed herein have physicochemical properties rendering them suitable for prolonged contact with living tissue, blood and the mucous membranes.
Further, notations such as "(meth)acrylate" or "(meth)acrylamide" are used herein to denote optional /-* methyl substitution. Thus, for example, methyl
(meth)acrylaye includes both methyl acrylate and methyl methacrylate, and N-alkyl (meth)acrylamide includes both N-alkyl acrylamide and N-alkyl methacrylamide.
The term "dibasic acid" is understood by those skilled in the field to describe compounds which contain groups, each of which supplies an hydrogen atom. The presence of two acid groups on these aforementioned dibasic acid compounds, and their anhydride forms where sterically possible, results in a reduction by one-half of the molar amount needed to be supplied to the reaction, as compared with conventional monobasic acids such as methacrylic acid. This is important because the hydrogel characteristics are drastically affected by even small increases in molar amounts of substituents used in the polymeric mix. For example, while a concentration of acid exceeding 10 weight percent might be desirable from a wettability standpoint, such a concentration may adversely affect other properties of the resulting hydrogel. The resulting polymeric film may have undesirable optical characteristics such as cloudiness, etc. When dibasic acids are used, only half the weight percent of the amount of monobasic acid need be used to obtain a comparable effect on the polymeric mixture. H
The preferred range of dibasic acid concentration is about from 0.5 weight percent of the polymeric hydrogel mix to about 10 weight percent, and more preferably from about 2 weight percent to about 5 weight percent.
The resulting hydrogels of the present invention show great promise as a superior material for various biomedical devices such as surgical implants, blood vessels, artificial ureters, artificial breast tissue and membranes intended to come into contact with body fluid outside of the body, e.g., membranes for kidney dialysis and heart/lung machines and the like. It is known that blood, for example, is readily and rapidly damaged when it comes into contact with artificial surfaces. The design of a synthetic surface which is antithrombogenic and nonhemolytic to blood is necessary for prostheses and devices used with blood.
Further, although the exact mechanisms are not fully understood at the present time, these hydrophilic bifunctional or dibasic carboxylic acid monomers appear to reduce the deposition problems normally associated with, and believed to be caused by, the high hydrophobicity of the hydrophobic silicone-containing monomers. Two preferred classes of silicone-containing monomers contemplated by the present invention are urethane-containing prepolymers, and ethylenically terminated polysiloxane containing monomers, such as, most preferably ,ω bis(methacryloxybutyl)polysiloxane (M2D2s) . The ethylenically unsaturated dibasic carboxylic acid containing monomer, (or the corresponding anhydride-containing monomer) of the present invention is preferably itaconic acid, maleic acid or their anhydrides, and fumaric acid, and most preferably are itaconic and maleic acid and their anhydrides.
The monomer mixes employed in this invention, can be readily cured to cast shapes by conventional methods such as UV polymerization, or thermal polymerization, or combinations thereof, as commonly used in polymerizing ethylenically unsaturated compounds. Representative free radical thermal polymerization initiators are organic peroxides, such as acetal peroxide, lauroyl peroxide, decanoyl peroxide, stearoyl peroxide, benzoyl peroxide, tertiarybutyl peroxypivalate, peroxydicarbonate, and the like, employed in a concentration of about 0.01 to 1 percent by weight of the total monomer mixture. Representative UV initiators are those known in the field such as, benzoin methyl ether, benzoin ethyl ether, Darocure 1173, 1164, 2273, / <-
1116, 2959, 3331 (EM Industries) and Igracure 651 and 184 (Ciba-Geigy) .
Polymerization of the crosslinker of this invention with other comonomers is generally performed in the presence of a diluent. The polymerization product will then be in the form of a gel. If the diluent is nonagueous, the diluent must be removed from the gel and replaced with water through the use of extraction and hydration protocols well known to those skilled in the art.
It is also possible to perform the polymerization in the absence of diluent to produce a xerogel. These xerogels may then be hydrated to form the hydrogels as is well known in the art.
In addition to the above-mentioned polymerization initiators, the copolymer of the present invention may also include other monomers as will be apparent to one skilled in the art. For example, the monomer mix may include additional hydrophilic monomers such as N-vinyl pyrrolidone and N,N-dimethylacrylamide, colorants, or UV-absorbing and toughening agents such as those known in the contact lens art. The polymers of this invention can be formed into contact lenses by εpincasting processes (such as those disclosed in U.S. Pat. Nos. 3,408,429 and 3,496,254), cast molding processes (such as those disclosed in U.S.
Pat. Nos. 4,084,459 and 4,197,266), or any other known method for making contact lenses. Polymerization may be conducted either in a spinning mold, or a stationary mold corresponding to a desired contact lens shape. The lens may be further subjected to mechanical finishing, as occasion demands. Polymerization may also be conducted in an appropriate mold or vessel to form buttons, plates or rods, which may then be processed
(e.g., cut or polished via lathe or laser) to give a contact lens having a desired shape.
The hydrogels of the present invention are oxygen transporting, hydrolytically stable, biologically inert, and transparent. The monomers and prepolymers employed in accordance with this invention, are readily polymerized to form three dimensional networks which permit the transport of oxygen and are optically clear, strong and hydrophilic.
The relative softness or hardness of the contact lenses fabricated from the resulting polymer of this invention can be varied by deceasing or increasing the molecular weight of the polysiloxane prepolymer end- capped with the activated unsaturated group or by varying the percent of the comonomer. Generally, as the ratio of polysiloxane units to end-cap units increases, the softness of the material increases.
Further, although the exact mechanisms are not fully understood at the present time, the hydrophilic ethylenically unsaturated dibasic acid monomers of the present invention significantly reduce the contact angle of the surface - a clear indication to those skilled in the field that enhanced wetting has occurred. The resulting dibasic acid- or anhydride-treated silicone- containing hydrogels were unexpectedly hydrolytically stable, within an acceptable range, while collecting only an acceptable level of deposits.
The resulting polymers and copolymers disclosed herein can be boiled and/or autoclaved in water without being damaged whereby sterilization may be achieved. Thus, an article formed from the disclosed polymers and copolymers may be used, for example, in surgery where an article is needed which is compatible with living tissue or with the mucous membranes.
The following examples serve only to further illustrate aspects of the present invention and should not be construed as limiting the invention. EXAMPLE 1 Preparation of Polyurethane Monomer Mix (Control)
A formulation containing the following was prepared: urethane prepolymer derived from isophorone diisocyanate, diethylene glycol, polysiloxanediol of molecular weight 3000 and 2-hydroxyethyl methacrylate, 35 parts; 3-methacryloxypropyl tris(trimethylsiloxy)silane, (TRIS), 35 parts; N,N- di ethyl acrylamide, 30 parts; n-hexanol, 40 parts; benzoin methyl ether, 0.2 part. The resulting clear mix was then UV cured into films or filtered through a 1.2 micron filter into a clean glass vial ready for lens casting.
EXAMPLE 2
Preparation of Polyurethane Monomer Mix Containing a Dibasic Acid Monomer.
Monomer mix was prepared as in Example 1 with the addition of 2 parts of maleic, itaconic or fumaric acid to the monomer mix.
_2_) EXAMPLE 3
Preparation of Polyurethane Monomer Mix Containing an Anhydride Monomer.
Monomer mix was prepared as in Example 1 with the addition of 2 parts of itaconic anhydride to the monomer mix.
EXAMPLE 4 Preparation of Dy Containing Monomer Mix a,ω -Bis(methylacryloxybutyl)polysiloxane (M2D25) prepared from the reaction of l,3-bis(4- methacryloxybutyl)disiloxane and 1,1,3,3,5,5-hexamethyl trisiloxane in molar ratio of 1:8.33 was mixed with TRIS, N,N-dimethyl acrylamide(DMA) , a solvent (hexanol) and an initiator (Daroσure-1173, EM Industries) in the following weight percent ratio:
EXAMPLE 5 oD^ mix with acid monomer
The monomer mixture of Example 4 was added with two parts of itaconic acid. -2/ EXAMPLE 6
Film Casting of Monomer Mixes
The resultant formulations from Examples 1 - 5 were placed between glass plates and cured under UV for 2 hours. After the films were released from the glass, they were extracetd with ethanol for 16 hours and then boiled in water for 4 hours and placed in buffered saline at pH 7.4. The hydrogel films were then characterized for mechanical properties, oxygen permeability, contact angle and others.
EXAMPLE 7
Comparison of Hvdrogel Properties
The following comparative properties of the control polyurethane films combined with 2 parts of the ethylenically unsaturated dibasic carboxylic acids are noted below.
Properties Control Itaconic Acid Maleic Acid
Water content % 24 34 36
Oxygen perm. (Dk) 100 81 89
Modulus g/mm2 100 150 110
Tear strength 15 7 13 The formulations containing the dibasic carboxylic acid monomers gave higher water content, while the other physical properties were virtually unaffected.
EXAMPLE 8
Hydrolvtic Stability Testing
The cured films, after being extracted with solvent
(ethanol) and dried in vacuo, were cut into disks weighing 30 g with a thickness of 250 microns. They were weighed while dry and were then submerged into buffered saline at pH 7.4 in 12 vials and sealed. After equilibration, the films were then placed in an oven at
80 degrees C. Three vials were taken out after 3, 5, 7 and 14 days and the dry weight and water contents were determined gravi etrically. The hydrolytic stabilities were reported as % weight loss after 14 day testing.
Low weight losses are more desirable. Experimentally, it was determined that resultant hydrogels having a weight loss of 7% or less would be considered stable.
The hydrolytic stability data of the control hydrogel film and those modified with two parts of dibasic acids are listed below.
Itaconic Maleic Methacrylic Control Acid Acid Acid
Hydrolytic
14 day 0.9 3.5 3.8 11.5 weight loss % £3
These results show that the hydrogel films comprising 2 parts of itaconic acid and maleic acid were considered stable. By comparison, hydrogel films derived from a formulation containing methacrylic acid were not as hydrolytically stable.
EXAMPLE 9 Lysozyme Uptake Tests
The tests were accomplished by agitating hydrogel films of known weight, (usually 30-40 mg) in a vial containing a standard buffered saline (5 grams) with 500 ppm of lysozyme for a 7 day period. The amount of lysozyme remaining in the solution was determined by UV spectroscopy and the lysozyme uptake was reported as micrograms of lysozyme per milligram of hydrogel film, using poly(hydroxyethylmethacrylate) (HEMA) hydrogel films as references. The comparative lysozyme uptakes of control hydrogel films and those modified with 2 parts dibasic acid are listed below.
Itaconic Maleic Methacrylic
Control Acid Acid Acid Lysozyme
Uptake 5 19 18 24
A high level of lysozome uptake is not desirable in contact lenses. Such uptake decreases visual acuity and can result in adverse eye physiological side effects. While it is desirable to add ionic monomers into the silicone-containing hydrogel to improve wettability, the lysozome uptake level should remain at a low level.
EXAMPLE 10 Contact Angle Measurement
The contact angles of the surface of the films prepared from formulations in Examples 1 and 2 were measured by the captive bubble technique. The films were submerged in buffered saline solution and a bubble of air was attached to the undersurface of the film. The angle made by the intersection of the lens and bubble surfaces was measured using a goniometer. A lower contact angle represents a greater degree of hydrophilicity, or film surface wettability. The comparative contact angles of control hydrogel films and those modified with dibasic acids are listed below.
Control Itaconic Acid Maleic Acid Contact Angle 38 27 28
The results show that the ionic nature of the ethylenically unsaturated dibasic carboxylic acid containing compounds and their anhydrides improve wettability of the resulting silicone-containing hydrogels. EXAMPLE 11 Cast Moldings of Polyurethane Lenses
A polyurethane monomer mix of composition described in Examples 1 and 2 was filtered through a disposable filter of pore size 1.2 microns, into a clean vial. Through an applicator, under an inert nitrogen atmosphere, 60-9Oul of the mix was injected onto a clean plastic mold (for the anterior surface of a lens) and then covered with a second plastic mold (forming the posterior surface of the lens) . The molds are then compressed and cured for 90 minutes in the presence of ultraviolet light (4200 microwatts/cm2) . The molds were opened mechanically and put in a beaker containing aqueous ethanol. The lenses were released from the mold within 10 to 50 minutes. The lenses were then extracted with ethanol for 48 hours, boiled in distilled water for 4 hours and inspected for cosmetic quality and dimension. Lenses passing inspection were thermally disinfected in phosphate-buffered saline prior to on-eye evaluation.
EXAMPLE 12 Clinical Evaluations
The cast molded lenses described in Example 11 were evaluated on six subjects. In each test, a poly(HEMA) control lens was worn on eye one and the test lens on the other eye. The lenses were analyzed after a minimum of one hour of wear, and optimally for 6 hours, for wettability and surface deposition. The wettability rating scale was 0-4 with 0 representing 2/3 of the anterior surface unwetted by the tear film and 4 representing complete wetting. The deposition scale was also 0-4 with 0 representing no surface deposit and 4 representing multiple deposits of 0.5mm diameter or larger. The results for the lenses of the control formulation made according to Example 1, was 2.0 for wetting and 1.6 for deposit after 1 hour of wear. For lenses comprising 2 parts of itaconic acid, the results showed a wettability rating of 3.0 and deposit rating of 0.3 after six hours of wear. This indicated that the lenses containing itaconic acid have superior wettability and deposit resistance characteristics resulting in a much higher rate of clinical acceptance.
Many other modifications and variations of the present invention are possible to the skilled practitioner in the field in light of the teachings herein. It is therefore understood that, within the scope of the claims, the present invention can be practiced other than as herein specifically described.

Claims

°Z7We Claim:
1. A method for making a wettable silicone-containing hydrogel composition comprising the steps of a) combining an ethylenically unsaturated dibasic acid or anhydride and at least one silicone-containing monomer into a monomer mix and b) curing the monomer mix resulting from step a) to form a silicone-containing hydrogel composition.
2. The method of Claim 1 wherein said silicone- containing monomer is a urethane-containing prepolymer.
3. The method of Claim 1 wherein said silicone- containing monomer is an ethylenically terminated polysiloxane-containing prepolymer.
4. The method of Claim 1 wherein said dibasic acid is selected from the group consisting of maleic acid, itaconic acid and fumaric acid.
5. The method of Claim 1 wherein said anhydride is selected from the group consisting of maleic anhydride and itaconic anhydride.
6. The method of Claim 1 wherein said silicone- containing monomer is a poly(organosiloxane) prepolymer represented by the formula:
R3 R5 R3
•7 I - 1 -7 A-(R')-Si-[O-Si]n-0-Si-(R7)-A
R4 R6 4
wherein:
A is an activated unsaturated group, such as an ester or amide of an acrylic or a methacrylic acid; each R3-Rδ is independently selected from the group consisting of a monovalent hydrocarbon radical or a halogen substituted monovalent hydrocarbon radical having 1 to 18 carbon atoms which may have ether linkages between carbon atoms;
R7 is a divalent hydrocarbon radical having from 1 to 22 carbon atoms; and n is 0 or an integer greater than or equal to 1.
7. The method of Claim 1 wherein said silicone- containing monomer is a bulky polysiloxanylalkyl (meth)acrylic monomer having the formula: R1
_*
wherein:
X is 0 or NR; each R is independently hydrogen or methyl; and each R1 is independently a lower alkyl or phenyl group; and f is 1 or 3 to 10.
8. The method of Claim 7 wherein said bulky polysiloxanyalkyl (meth)acrylate monomer is selected from the group consisting of methacryloxypropyl tris(trimethylsiloxy)silane, pentamethyldisiloxanylmethylmethacrylate, tris(trimethylsiloxy)methacryloxy propylsilane, phenyltetramethyldisiloxanylethyl acetate, and methyldi(trimethylsiloxy)methacryloxymethyl silane.
9. The method of Claim 1 wherein said silicone- containing monomer is a urethane-containing prepolymer having the following schematic representations: 3o
E ( *D*A" *D*G) a*D*A" *D*E ' ; or E(*D*G*D*A" ) a*D*G*D*E' ; wherein
D denotes an alkyl diradical, an alkyl cycloalkyl diradical, a cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 6 to 30 carbon atoms;
G denotes an alkyl diradical, a cycloalkyl diradical, an alkyl cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 1 to 40 carbon atoms and which may contain ether, thio or amine linkages in the main chain;
* denotes a urethane or ureido linkage; a is at least 1;
A denotes a divalent polymeric radical of formula :
m-
wherein: Rs and Rs independently denote an alkyl or fluoro-substituted alkyl group having 1 to 10 carbon atoms which may contain ether linkages between carbon atoms; m is at least 1; and p provides a moiety weight of 400 to 10,000; E and E' independently denote a polymerizable unsaturated organic radical represented by formula:
R12 R13-CH=C-(CH2)w-(X)x-(Z)2-(Ar)y-R14- wherein: R14 denotes a divalent alkylene radical having 1 to 10 carbon atoms;
R12 denotes H or CH3;
R13 denotes H, a (C^-Cg) alkyl radical or a -CO-Y-R15 group wherein Y is -0-, -S- or -NH- and R15 is a alkyl radical having 1 to 12 carbon atoms; X is -CO- or -0C0-; Z is -O- or -NH-;
Ar denotes an aromatic radical having 6 to 30 carbon atoms; w is 0 to 6; x is 0 or 1; y is 0 or 1; and z is 0 or 1.
10. The method of Claim 9 wherein said urethane- containing prepolymer is represented by formula:
&
CH3 I
H2C=C H H H H I COOCH2CH2
CH3-Si-CH3
(CH2)m
CH3
H2C=C H H H H I I 1
COOCH2CH2OCN-R16- COCH2CH2OCH2CH2OCN-R16-NCO —'
11 H II 0 O 0
wherein:
R16 is a diradical of a diisocyanate after removal of the isocyanate group and m, p and a are the same as previously defined.
11. A silicone-containing hydrogel composition comprising an ethylenically unsaturated dibasic acid or anhydride and a silicone-containing monomer.
12. The hydrogel of Claim 11 wherein said silicone- containing monomer is a urethane-containing prepolymer.
13. The hydrogel of Claim 11 wherein said silicone- containing monomer is an ethylenically terminated polysiloxane-containing prepolymer.
14. The hydrogel of Claim 11 wherein said dibasic acid is selected from the group consisting of maleic acid, itaconic acid and fumaric acid.
15. The hydrogel of Claim 11 wherein said anhydride is selected from the group consisting of maleic anhydride and itaconic anhydride.
16. The hydrogel of Claim 11 wherein said silicone- containing monomer is a poly(organosiloxane) prepolymer represented by the formula:
R3 R5 R3 I
A-(R/)-Si-[0-Si]n-0-Si-(R7)-A
wherein:
A is an activated unsaturated group, such as an ester or amide of an acrylic or a methacrylic acid; each R3-R6 is independently selected from the group consisting of a monovalent hydrocarbon radical or a halogen substituted monovalent hydrocarbon radical having 1 to 18 carbon atoms which may have ether linkages between carbon atoms; R7 is a divalent hydrocarbon radical having from 1 to 22 carbon atoms; and n is 0 or an integer greater than or equal to 1.
17. The hydrogel of Claim 11 wherein said silicone- containing monomer is a bulky polysiloxanylalkyl (meth)acrylic monomer having the formula:
R1
I
R^- SSi-R1
R1— Si-R1
wherein:
X is O or NR; each R is independently hydrogen or methyl; and each R1 is independently a lower alkyl or phenyl group; and f is 1 or 3 to 10.
18. The hydrogel of Claim 17 wherein said bulky polysiloxanyalkyl (meth)acrylic monomer is selected from the group consisting of methacryloxypropyl tris(trimethylsiloxy)silane, pentamethyldisiloxanylmethylmethacrylate, tris(trimethylsiloxy)methacryloxy propylsilane, phenyltetramethyldisiloxanylethyl acetate, and methyldi(trimethylsiloxy)methacryloxymethyl silane.
19. The hydrogel of Claim 11 wherein said silicone- containing monomer is a urethane-containing prepolymer having the following schematic representations:
E(*D*A"*D*G)a*D*A"*D*E' ; or E(*D*G*D*A")a*D*G*D*E' ; wherein
D denotes an alkyl diradical, an alkyl cycloalkyl diradical, a cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 6 to 30 carbon atoms;
G denotes an alkyl diradical, a cycloalkyl diradical, an alkyl cycloalkyl diradical, an aryl diradical or an alkylaryl diradical having 1 to 40 carbon atoms and which may contain ether, thio or amine linkages in the main chain;
* denotes a urethane or ureido linkage; a is at least 1;
A" denotes a divalent polymeric radical of formula: G&
f
- (CH2 ) m -Si-O- -Si (CH2 ) m- l .. .
wherein: Rε and Rs independently denote an alkyl or fluoro-substituted alkyl group having 1 to 10 carbon atoms which may contain ether linkages between carbon atoms; m is at least 1; and p provides a moiety weight of 400 to 10,000; E and EΛ independently denote a polymerizable unsaturated organic radical represented by formula:
,12
R13-CH=C-(CH2)w-(X)χ-(Z)z-(Ar)y-R14- wherein: R ,14 denotes a divalent alkylene radical having 1 to 10 carbon atoms;
R12 denotes H or CH3;
R13 denotes H, a (C^-Cg) alkyl radical or a -C0-Y-R15 group wherein Y is -0-, -S- or -NH- and R15 is a alkyl radical having 1 to 12 carbon atoms;
X is -CO- or -0C0-;
Z is -O- or -NH-;
Ar denotes an aromatic radical having 6 to 30 carbon atoms; w is 0 to 6; x is 0 or 1; y is 0 or 1; and z is 0 or 1.
20. The hydrogel of Claim 19 wherein said urethane- containing prepolymer is represented by formula:
CH3
CH3-Si-CH3
(CH2)m
CH3
/
H2C=C H H H H I I I
COOCH2CH2OCN-R16-NCOCH2CH2OCH2CH2OCN-R16-NCO
II II H 1/ o o 0 o
wherein:
R16 is a diradical of a diisocyanate after removal of the isocyanate group and m, p and a are the same as previously defined.
21. The hydrogel of Claim 11 wherein said silicone- containing monomer is a,ω bis(methacryloxybutyl) polysiloxane, and said ethylenically unsaturated dibasic carboxylic acid containing monomers and corresponding acid anhydride containing monomer is selected from the group consisting of itaconic acid and itaconic acid anhydride.
22. The hydrogel of Claim 11 wherein said silicone- containing monomer is α,_. bis(methacryloxybutyl) polysiloxane, and said ethylenically unsaturated dibasic carboxylic acid containing monomer and corresponding acid anhydride containing monomer is selected from the group consisting of maleic acid and maleic acid anhydride.
23. The hydrogel of Claim 11 wherein said silicone- containing monomer is α,_> bis(methacryloxybutyl) polysiloxane, and said ethylenically unsaturated dibasic carboxylic acid containing monomer is fumaric acid.
24. The hydrogel of Claim 11 wherein said silicone- containing monomer is a urethane-containing prepolymer, said ethylenically unsaturated dibasic carboxylic acid containing monomer and said corresponding acid anhydride containing monomer is selected from the group consisting of itaconic acid and itaconic acid anhydride.
25. The method of Claim 11 wherein said silicone- containing monomer is a urethane-containing prepolymer and said ethylenically unsaturated dibasic carboxylic acid containing monomer and corresponding acid anhydride containing monomer is selected from the group consisting of maleic acid and maleic acid anhydride.
26. The method of Claim 11 wherein said silicone- containing monomer is a urethane-containing prepolymer and said ethylenically unsaturated dibasic carboxylic acid containing monomer is fumaric acid.
27. A biomedical device made from the hydrogel composition of Claim 11.
28. A contact lens made from the hydrogel composition of Claim 11.
EP92919325A 1991-09-12 1992-08-28 Wettable silicone hydrogel compositions and methods for making them Ceased EP0603270A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US75804791A 1991-09-12 1991-09-12
US758047 1991-09-12
US92259592A 1992-07-30 1992-07-30
US922595 1992-07-30
PCT/US1992/007322 WO1993005098A1 (en) 1991-09-12 1992-08-28 Wettable silicone hydrogel compositions and methods

Publications (1)

Publication Number Publication Date
EP0603270A1 true EP0603270A1 (en) 1994-06-29

Family

ID=27116484

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92919325A Ceased EP0603270A1 (en) 1991-09-12 1992-08-28 Wettable silicone hydrogel compositions and methods for making them

Country Status (6)

Country Link
EP (1) EP0603270A1 (en)
JP (1) JPH06510811A (en)
BR (1) BR9206600A (en)
CA (1) CA2116848A1 (en)
MX (1) MX9205183A (en)
WO (1) WO1993005098A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0877037B1 (en) * 1997-05-02 2001-06-27 Wacker-Chemie GmbH Process for the preparation of organopolysiloxane compositions having (methyl)styrene groups by curing with UV light

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358995A (en) * 1992-05-15 1994-10-25 Bausch & Lomb Incorporated Surface wettable silicone hydrogels
US6020445A (en) * 1997-10-09 2000-02-01 Johnson & Johnson Vision Products, Inc. Silicone hydrogel polymers
US6367929B1 (en) 1998-03-02 2002-04-09 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
WO1999056167A1 (en) * 1998-04-28 1999-11-04 Toray Industries, Inc. Process for producing ocular lens
BRPI0515934B8 (en) * 2004-09-29 2021-07-27 Aortech Biomaterials Pty Ltd chemical gel, its preparation process, biomaterial, device, article or implant, breast implant, and filler material for a medical implant
EP1913029A1 (en) 2005-08-10 2008-04-23 Novartis AG Silicone hydrogels
WO2007121513A1 (en) 2006-04-20 2007-11-01 Aortech Biomaterials Pty Ltd Gels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486577A (en) * 1982-10-12 1984-12-04 Ciba-Geigy Corporation Strong, silicone containing polymers with high oxygen permeability
US4543398A (en) * 1983-04-28 1985-09-24 Minnesota Mining And Manufacturing Company Ophthalmic devices fabricated from urethane acrylates of polysiloxane alcohols
US4605712A (en) * 1984-09-24 1986-08-12 Ciba-Geigy Corporation Unsaturated polysiloxanes and polymers thereof
ATE106424T1 (en) * 1987-04-30 1994-06-15 Ciba Geigy Ag MACROMERS CONTAINING TERMINAL VINYL GROUPS, DERIVED POLYMERS AND CONTACT LENSES.
US5034461A (en) * 1989-06-07 1991-07-23 Bausch & Lomb Incorporated Novel prepolymers useful in biomedical devices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9305098A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0877037B1 (en) * 1997-05-02 2001-06-27 Wacker-Chemie GmbH Process for the preparation of organopolysiloxane compositions having (methyl)styrene groups by curing with UV light

Also Published As

Publication number Publication date
MX9205183A (en) 1993-05-01
BR9206600A (en) 1995-10-17
JPH06510811A (en) 1994-12-01
CA2116848A1 (en) 1993-03-13
WO1993005098A1 (en) 1993-03-18

Similar Documents

Publication Publication Date Title
US5451617A (en) Wettable silicone hydrogel compositions and methods for their manufacture
CA2121579C (en) Wettable silicone hydrogel compositions and methods for their manufacture
EP0611379B1 (en) Wettable silicone hydrogel compositions and methods for their manufacture
US5496871A (en) Fumarate and fumaramide siloxane hydrogel compositions
US5387632A (en) Surface wettable silicone hydrogels
EP0683799B1 (en) Fluorosilicone hydrogels
EP0030807B1 (en) Shaped biomedical articles made of polysiloxane polymers
US7176268B2 (en) Prepolymers for improved surface modification of contact lenses
US20050124719A1 (en) Surface modification of contact lenses
EP0603270A1 (en) Wettable silicone hydrogel compositions and methods for making them
US8101698B2 (en) Surface active prepolymers with both fluorine-containing groups and hydrophilic groups
US20090012250A1 (en) Novel polymerizable surface active monomers with both fluorine-containing groups and hydrophilic groups

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19940311

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE ES FR GB IE IT

17Q First examination report despatched

Effective date: 19951120

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 19960926